v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Revenue:        
Total revenues $ 37,958 $ 3,500 $ 57,753 $ 3,500
Operating expenses:        
Cost of Product Sales 1,279 0 2,164 0
Research and development 62,227 48,655 123,863 105,147
Selling, general and administrative 43,805 29,061 84,836 52,083
Total operating expenses 107,311 77,716 210,863 157,230
Loss from operations (69,353) (74,216) (153,110) (153,730)
Other income (expense), net:        
Royalty interest expense (7,854) 0 (15,903) 0
Other interest expense (4) (45) (6) (100)
Interest income 5,950 6,284 13,133 13,540
Other expense (586) (86) (807) (173)
Total other income, net (2,494) 6,153 (3,583) 13,267
Net loss (71,847) (68,063) (156,693) (140,463)
Net loss attributable to common stockholders $ (71,847) $ (68,063) $ (156,693) $ (140,463)
Net loss per share attributable to common stockholders—basic $ (0.83) $ (0.8) $ (1.82) $ (1.65)
Net loss per share attributable to common stockholders—diluted $ (0.83) $ (0.8) $ (1.82) $ (1.65)
Weighted-average number of common shares used to compute net loss per share attributable to common stockholders —basic 86,337,237 85,274,829 86,255,020 85,244,015
Weighted-average number of common shares used to compute net loss per share attributable to common stockholders—diluted 86,337,237 85,274,829 86,255,020 85,244,015
Product        
Revenue:        
Total revenues $ 28,600 $ 0 $ 48,642 $ 0
Collaboration revenue        
Revenue:        
Total revenues 9,358 0 9,111 0
Milestone Revenue        
Revenue:        
Total revenues $ 0 $ 3,500 $ 0 $ 3,500